Health Catalyst’s (HCAT) Equal Weight Rating Reaffirmed at Wells Fargo & Company

Wells Fargo & Company reiterated their equal weight rating on shares of Health Catalyst (NASDAQ:HCAT) in a report issued on Wednesday morning, MarketBeat reports. They currently have a $1.00 price target on the stock, down from their previous price target of $5.00.

Other research analysts have also issued reports about the company. Canaccord Genuity Group lowered their price target on Health Catalyst from $5.00 to $2.00 and set a “buy” rating on the stock in a report on Friday, March 13th. Stephens decreased their target price on shares of Health Catalyst from $3.50 to $2.00 and set an “equal weight” rating for the company in a research report on Friday, March 13th. Cantor Fitzgerald lowered their target price on shares of Health Catalyst from $4.00 to $3.00 and set a “neutral” rating on the stock in a research note on Friday, March 13th. Raymond James Financial set a $3.00 price target on shares of Health Catalyst in a research report on Friday, March 13th. Finally, Citigroup reduced their price target on shares of Health Catalyst from $2.75 to $1.75 and set a “neutral” rating for the company in a research note on Friday, March 13th. Four analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Health Catalyst has a consensus rating of “Hold” and a consensus target price of $2.80.

Health Catalyst Stock Performance

Shares of NASDAQ HCAT opened at $1.16 on Wednesday. Health Catalyst has a 12-month low of $1.04 and a 12-month high of $5.06. The company has a market cap of $85.36 million, a PE ratio of -0.46 and a beta of 1.76. The stock has a 50 day simple moving average of $1.98 and a 200-day simple moving average of $2.51. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.62.

Health Catalyst (NASDAQ:HCAT) last posted its earnings results on Thursday, March 12th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.02). The business had revenue of $74.68 million during the quarter, compared to analyst estimates of $73.99 million. Health Catalyst had a negative net margin of 57.20% and a negative return on equity of 4.30%. On average, equities research analysts forecast that Health Catalyst will post -0.33 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of HCAT. AQR Capital Management LLC raised its position in Health Catalyst by 816.8% in the first quarter. AQR Capital Management LLC now owns 168,344 shares of the company’s stock worth $763,000 after acquiring an additional 149,981 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Health Catalyst by 7.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company’s stock valued at $163,000 after purchasing an additional 2,624 shares in the last quarter. Focus Partners Wealth bought a new position in shares of Health Catalyst during the 1st quarter valued at about $46,000. Campbell & CO Investment Adviser LLC grew its stake in shares of Health Catalyst by 9.7% in the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 43,051 shares of the company’s stock worth $162,000 after purchasing an additional 3,808 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Health Catalyst by 11.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock worth $6,269,000 after purchasing an additional 169,580 shares during the last quarter. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.